Background:
Long non-coding RNAs (lncRNAs), a type of regulatory RNAs, play a key
role in numerous cellular pathways. Ectopic expression of this group of non-coding RNAs has been
specified to be involved in numerous diseases. Moreover, the role of lncRNAs in the initiation and
development of cancers including colorectal cancer (CRC) has been acknowledged.
Objective:
In the present review, the role of lncRNAs as prognostic and diagnostic biomarkers in
CRC as well as the molecular mechanisms of their contribution to development of CRC has been
addressed.
Results:
The presented studies have indicated the ectopic expression of various lncRNAs in CRC.
Some lncRNAs which were considered as tumor suppressors were downregulated in the colorectal
cancerous tissues compared with healthy controls; however, some with oncogenic effects were
upregulated. LncRNAs contribute to tumor development via various molecular mechanisms such as
epigenetically controlling the expression of target genes, interacting with miRNAs as their sponge,
etc.
Conclusion:
LncRNAs that have been recognized as prognostic biomarkers may pave the way for
clinical management to offer adjuvant treatments for patients with CRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.